Human Tissue Microarray (HN085-01A)
Head and Neck Tumor Tissue Microarraay - 2 cores per case
- 40 Squamous Cell carcinoma cases
- 2 Adenocarcinoma cases
$255.00
Species | Human |
---|---|
Section Thickness | 5 µm |
Fixative | Formalin |
Total Cases | 42 |
Total Cores | 85 |
Core Diameter | 1.0 mm |
Storage | Short term RT |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- B
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- C
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- D
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- E
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- F
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- G
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- H
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- HE
- I
- HE
- HE
- HE
- HE
- HE
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Block ID |
---|---|---|---|---|---|---|---|---|---|---|
1
|
A1
|
61
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T4aN2M0
|
IVA
|
Malignant Primary
|
16-12771D
|
2
|
A2
|
61
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T4aN2M0
|
IVA
|
Malignant Primary
|
16-12771D
|
3
|
A3
|
72
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
17-7175E
|
4
|
A4
|
72
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
17-7175E
|
5
|
A5
|
62
|
F
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G3
|
T2N2M0
|
N/A
|
Malignant Primary
|
21113142A
|
6
|
A6
|
62
|
F
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G3
|
T2N2M0
|
N/A
|
Malignant Primary
|
21113142A
|
7
|
A7
|
67
|
F
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G3
|
T3N1M0
|
N/A
|
Malignant Primary
|
21113143A
|
8
|
A8
|
67
|
F
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G3
|
T3N1M0
|
N/A
|
Malignant Primary
|
21113143A
|
9
|
A9
|
56
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T4N3M0
|
N/A
|
Malignant Primary
|
21113144A
|
10
|
A10
|
56
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T4N3M0
|
N/A
|
Malignant Primary
|
21113144A
|
11
|
B1
|
57
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G3
|
T4N0M0
|
N/A
|
Malignant Primary
|
21113146A
|
12
|
B2
|
57
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G3
|
T4N0M0
|
N/A
|
Malignant Primary
|
21113146A
|
13
|
B3
|
55
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T3N3M0
|
N/A
|
Malignant Primary
|
21113147A
|
14
|
B4
|
55
|
M
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T3N3M0
|
N/A
|
Malignant Primary
|
21113147A
|
15
|
B5
|
45
|
F
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T4N3M0
|
N/A
|
Malignant Primary
|
21113148A
|
16
|
B6
|
45
|
F
|
Head and neck: Oropharynx and Oral cavity, Lip
|
Squamous Cell Carcinoma
|
G2
|
T4N3M0
|
N/A
|
Malignant Primary
|
21113148A
|
17
|
B7
|
55
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T3N1M0
|
N/A
|
Malignant Primary
|
21113669A
|
18
|
B8
|
55
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T3N1M0
|
N/A
|
Malignant Primary
|
21113669A
|
19
|
B9
|
54
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N2M0
|
N/A
|
Malignant Primary
|
21113670A
|
20
|
B10
|
54
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N2M0
|
N/A
|
Malignant Primary
|
21113670A
|
21
|
C1
|
63
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T4N0M0
|
N/A
|
Malignant Primary
|
21113672A
|
22
|
C2
|
63
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T4N0M0
|
N/A
|
Malignant Primary
|
21113672A
|
23
|
C3
|
70
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T4N0M0
|
N/A
|
Malignant Primary
|
21113673A
|
24
|
C4
|
70
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T4N0M0
|
N/A
|
Malignant Primary
|
21113673A
|
25
|
C5
|
66
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T2N2M0
|
N/A
|
Malignant Primary
|
21113674A
|
26
|
C6
|
66
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T2N2M0
|
N/A
|
Malignant Primary
|
21113674A
|
27
|
C7
|
55
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T4N1M0
|
N/A
|
Malignant Primary
|
21113675A
|
28
|
C8
|
55
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T4N1M0
|
N/A
|
Malignant Primary
|
21113675A
|
29
|
C9
|
54
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T3N2M0
|
N/A
|
Malignant Primary
|
21113677A
|
30
|
C10
|
54
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T3N2M0
|
N/A
|
Malignant Primary
|
21113677A
|
31
|
D1
|
40
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
N/A
|
Malignant Primary
|
21113678A
|
32
|
D2
|
40
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
N/A
|
Malignant Primary
|
21113678A
|
33
|
D3
|
53
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T2N1M0
|
N/A
|
Malignant Primary
|
21113679A
|
34
|
D4
|
53
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T2N1M0
|
N/A
|
Malignant Primary
|
21113679A
|
35
|
D5
|
62
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T2N3M0
|
N/A
|
Malignant Primary
|
21113681A
|
36
|
D6
|
62
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T2N3M0
|
N/A
|
Malignant Primary
|
21113681A
|
37
|
D7
|
56
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
N/A
|
Malignant Primary
|
21113682A
|
38
|
D8
|
56
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
N/A
|
Malignant Primary
|
21113682A
|
39
|
D9
|
45
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T2N0M0
|
II
|
Malignant Primary
|
21116531A
|
40
|
D10
|
45
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T2N0M0
|
II
|
Malignant Primary
|
21116531A
|
41
|
E1
|
44
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21116532A
|
42
|
E2
|
44
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21116532A
|
43
|
E3
|
46
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21116536A
|
44
|
E4
|
46
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21116536A
|
45
|
E5
|
62
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N2M0
|
IVA
|
Malignant Primary
|
21116537A
|
46
|
E6
|
62
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N2M0
|
IVA
|
Malignant Primary
|
21116537A
|
47
|
E7
|
57
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T2N0M0
|
II
|
Malignant Primary
|
21116538A
|
48
|
E8
|
57
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T2N0M0
|
II
|
Malignant Primary
|
21116538A
|
49
|
E9
|
65
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
IVA
|
Malignant Primary
|
21112123A
|
50
|
E10
|
65
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
IVA
|
Malignant Primary
|
21112123A
|
51
|
F1
|
65
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
21112125A
|
52
|
F2
|
65
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
21112125A
|
53
|
F3
|
46
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
III
|
Malignant Primary
|
21112126A
|
54
|
F4
|
46
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
III
|
Malignant Primary
|
21112126A
|
55
|
F5
|
63
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T4aN2M0
|
IVA
|
Malignant Primary
|
21112127A
|
56
|
F6
|
63
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T4aN2M0
|
IVA
|
Malignant Primary
|
21112127A
|
57
|
F7
|
59
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T4aN0M0
|
IVA
|
Malignant Primary
|
21112128A
|
58
|
F8
|
59
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T4aN0M0
|
IVA
|
Malignant Primary
|
21112128A
|
59
|
F9
|
48
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21112129A
|
60
|
F10
|
48
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21112129A
|
61
|
G1
|
57
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
IVA
|
Malignant Primary
|
21112130A
|
62
|
G2
|
57
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
IVA
|
Malignant Primary
|
21112130A
|
63
|
G3
|
61
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
21112131A
|
64
|
G4
|
61
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
21112131A
|
65
|
G5
|
57
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21112132A
|
66
|
G6
|
57
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N1M0
|
III
|
Malignant Primary
|
21112132A
|
67
|
G7
|
81
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
IVA
|
Malignant Primary
|
21112133A
|
68
|
G8
|
81
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T2N2M0
|
IVA
|
Malignant Primary
|
21112133A
|
69
|
G9
|
94
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
III
|
Malignant Primary
|
21112134A
|
70
|
G10
|
94
|
F
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
III
|
Malignant Primary
|
21112134A
|
71
|
H1
|
63
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
III
|
Malignant Primary
|
21112135A
|
72
|
H2
|
63
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T3N0M0
|
III
|
Malignant Primary
|
21112135A
|
73
|
H3
|
61
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
21112136A
|
74
|
H4
|
61
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N1M0
|
III
|
Malignant Primary
|
21112136A
|
75
|
H5
|
62
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N0M0
|
III
|
Malignant Primary
|
21112137A
|
76
|
H6
|
62
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G1
|
T3N0M0
|
III
|
Malignant Primary
|
21112137A
|
77
|
H7
|
62
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T2N1M0
|
III
|
Malignant Primary
|
21112138A
|
78
|
H8
|
62
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G2
|
T2N1M0
|
III
|
Malignant Primary
|
21112138A
|
79
|
H9
|
72
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
21112139A
|
80
|
H10
|
72
|
M
|
Head and neck
|
Squamous Cell Carcinoma
|
G3
|
T3N1M0
|
III
|
Malignant Primary
|
21112139A
|
81
|
I1
|
40
|
M
|
Head and neck
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
444
|
82
|
I2
|
40
|
M
|
Head and neck
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
444
|
83
|
I3
|
91
|
F
|
Head and neck
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
610
|
84
|
I4
|
91
|
F
|
Head and neck
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
610
|
85
|
I5
|
91
|
F
|
Head and neck
|
Matched NAT - I3/I4
|
-
|
-
|
-
|
Normal
|
610
|